Submission Details
| 510(k) Number | K223105 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 30, 2022 |
| Decision Date | December 22, 2022 |
| Days to Decision | 83 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
K223105 is an FDA 510(k) clearance for the Tesera-K SC System, a Intervertebral Fusion Device With Integrated Fixation, Cervical (Class II — Special Controls, product code OVE), submitted by Kyocera Medical Technologies, Inc. (Redlands, US). The FDA issued a Cleared decision on December 22, 2022, 83 days after receiving the submission on September 30, 2022. This device falls under the Orthopedic review panel. Regulated under 21 CFR 888.3080.
| 510(k) Number | K223105 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 30, 2022 |
| Decision Date | December 22, 2022 |
| Days to Decision | 83 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
| Product Code | OVE — Intervertebral Fusion Device With Integrated Fixation, Cervical |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 888.3080 |
| Definition | Intended To Stabilize Cervical Spinal Segment To Promote Fusion In Order To Restrict Motion And Decrease Pain Using Bone Graft With Or Without Supplemental Fixation. |